<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22863" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hidradenitis Suppurativa</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ballard</surname>
            <given-names>Kimberly</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shuman</surname>
            <given-names>Victoria L.</given-names>
          </name>
          <aff>WV Sch Osteo Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kimberly Ballard declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Victoria Shuman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22863.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hidradenitis suppurativa is a chronic inflammatory skin condition characterized by painful lesions such as deep-seated nodules, abscesses, skin tunnels, and fibrotic scars. These manifestations primarily emerge in intertriginous areas, notably the axillary, groin, perianal, perineal, and inframammary regions.&#x000a0;The condition's impact extends beyond physical discomfort, with associated pain, drainage, malodor, and scarring often leading to profound negative psychosocial implications for affected individuals.</p>
        <p>The diagnosis&#x000a0;of hidradenitis suppurativa is clinically based but often challenging and delayed, exacerbating the patient experience. Different grading criteria, including the Hurley classification, are available to guide treatment. Laboratory and imaging tests help characterize the lesions and rule out other conditions.&#x000a0;</p>
        <p>Treatment involves lifestyle modifications, medications such as antibiotics and anti-inflammatory drugs, procedures like laser therapy and excision&#x000a0;with&#x000a0;skin grafting.&#x000a0;Supportive therapies like pain management and psychological support may also benefit patients.&#x000a0;Interprofessional&#x000a0;care&#x000a0;is crucial to&#x000a0;creating&#x000a0;a personalized treatment plan, with regular follow-up appointments to monitor effectiveness and make adjustments as necessary.</p>
        <p>This&#x000a0;activity for healthcare professionals is designed to enhance learners' competence in evaluating and managing hidradenitis suppurativa. Participants gain profound insights into the condition's etiology, clinical presentation, complications, and therapeutic strategies. Learners become equipped to collaborate effectively within an interprofessional team to enhance outcomes for individuals with&#x000a0;hidradenitis suppurativa.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine the&#x000a0;potential triggers&#x000a0;of hidradenitis suppurativa.</p></list-item><list-item><p>Identify&#x000a0;the clinical presentation of hidradenitis suppurativa.</p></list-item><list-item><p>Implement an individualized treatment&#x000a0;plan for&#x000a0;patients with hidradenitis suppurativa.</p></list-item><list-item><p>Apply effective strategies to improve care coordination among interprofessional team members to address complications and comorbidities for patients with&#x000a0;hidradenitis suppurativa.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22863&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22863">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22863.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hidradenitis suppurativa (acne inversa or Verneuil disease)&#x000a0;is a chronic inflammatory skin condition of follicular occlusion&#x000a0;with lesions including deep-seated nodules and abscesses, draining&#x000a0;skin tunnels (also called&#x000a0;sinus tracts&#x000a0;or fistulae), and fibrotic scars.<xref ref-type="bibr" rid="article-22863.r1">[1]</xref><xref ref-type="bibr" rid="article-22863.r2">[2]</xref>&#x000a0;These lesions most commonly occur in intertriginous areas,&#x000a0;though they may present in any location with&#x000a0;folliculopilosebaceous units.&#x000a0;The most commonly affected areas are the axillary,&#x000a0;groin, perianal, perineal, and inframammary&#x000a0;regions (see&#x000a0;<bold>Image</bold>. Hidradenitis Suppurativa, Left Axilla).<xref ref-type="bibr" rid="article-22863.r3">[3]</xref><xref ref-type="bibr" rid="article-22863.r4">[4]</xref></p>
        <p>Treatment varies based on severity and&#x000a0;may include topical and systemic antibiotics, hormone therapy, immune modulators, and surgery.<xref ref-type="bibr" rid="article-22863.r5">[5]</xref>&#x000a0;This condition may have a negative psychosocial impact&#x000a0;because of the associated pain, involvement of sensitive locations, drainage, odor,&#x000a0;disfigurement, and scarring. Late diagnosis only worsens the patient experience.<xref ref-type="bibr" rid="article-22863.r6">[6]</xref><xref ref-type="bibr" rid="article-22863.r7">[7]</xref></p>
        <p>
<bold>Skin&#x000a0;Histology</bold>
</p>
        <p>Skin appendages&#x000a0;include&#x000a0;the&#x000a0;pilosebaceous units, sweat glands, and nails, which possess&#x000a0;distinct functions and histological features.&#x000a0;The pilosebaceous unit is the assembly formed by the hair shaft, follicle,&#x000a0;sebaceous gland, and arrector pili muscle. This group of skin appendages develops from the epidermis during fetal development. The hair shaft is visible on the skin's surface and&#x000a0;is comprised&#x000a0;of&#x000a0;cuticle cells surrounding a cortex, with a medulla present in thicker hair. The hair follicle is essential for hair growth and is histologically divided into the infundibulum, isthmus, and inferior segment, with stem cells residing in the bulge area.&#x000a0;Sebaceous glands are pilosebaceous unit&#x000a0;components that produce sebum to lubricate hair. These glands have a foamy appearance microscopically due to their lipid content.</p>
        <p>Sweat glands (sudoriferous glands) are categorized as eccrine or apocrine, which differ in their distribution and secretion mode. Eccrine glands are present in the dermis and upper hypodermis throughout the body and exhibit merocrine secretion, where the cytoplasm remains intact during secretion.&#x000a0;Apocrine glands&#x000a0;are&#x000a0;found in the dermis and subcutanous fat&#x000a0;in areas like the intertriginous&#x000a0;zones.&#x000a0;These glands&#x000a0;lose&#x000a0;the top&#x000a0;portions of the cellular cytoplasm during secretion. Histologically, eccrine glands consist of coiled secretory&#x000a0;segments&#x000a0;surrounded by myoepithelial cells, while apocrine glands have less coiling and larger lumens lined by cuboidal epithelial cells.</p>
        <p>Nails consist of the nail plate, matrix, eponychium, hyponychium, nail folds, and lunula.&#x000a0;The matrix&#x000a0;serves&#x000a0;as the site of nail formation. The nail plate&#x000a0;is composed of&#x000a0;compact keratinocytes and lacks desquamation, contributing to its rigidity and translucency. The hyponychium lies beneath the nail plate, lacks a granular layer, and contains a rich vascular network.&#x000a0;The eponychium serves as a pathogen barrier.<xref ref-type="bibr" rid="article-22863.r8">[8]</xref></p>
      </sec>
      <sec id="article-22863.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The&#x000a0;development of&#x000a0;hidradenitis suppurativa&#x000a0;appears to have genetic, environmental, and behavioral influences.<xref ref-type="bibr" rid="article-22863.r9">[9]</xref>&#x000a0;Approximately 33% to 40% of individuals with hidradenitis suppurativa report an affected first-degree relative, suggesting a hereditary component with an autosomal dominant transmission pattern.<xref ref-type="bibr" rid="article-22863.r10">[10]</xref>&#x000a0;Researchers have identified a loss-of-function mutation of the &#x003b3;-secretase complex involved in the Notch signaling pathway in a small subset of affected families.<xref ref-type="bibr" rid="article-22863.r11">[11]</xref>&#x000a0;Other mutations identified in hidradenitis suppurativa include <italic toggle="yes">DCD</italic> (encoding dermcidin),&#x000a0;<italic toggle="yes">PSTPIP1&#x000a0;(</italic>found in hidradenitis suppurativa syndromes),&#x000a0;<italic toggle="yes">SOX9,</italic>&#x000a0;and&#x000a0;<italic toggle="yes">KLF5</italic>&#x000a0;genes.<xref ref-type="bibr" rid="article-22863.r12">[12]</xref><xref ref-type="bibr" rid="article-22863.r13">[13]</xref><xref ref-type="bibr" rid="article-22863.r14">[14]</xref></p>
        <p>Environmental and behavioral factors are vital&#x000a0;in hidradenitis suppurativa's development. Individuals with&#x000a0;this condition&#x000a0;often have comorbidities such as obesity, leading to increased skin friction, sweat production and retention, and hormonal changes, particularly androgen excess.<xref ref-type="bibr" rid="article-22863.r15">[15]</xref><xref ref-type="bibr" rid="article-22863.r16">[16]</xref>&#x000a0;Metabolic syndrome, more prevalent in obesity, is also observed in&#x000a0;hidradenitis suppurativa cases.<xref ref-type="bibr" rid="article-22863.r17">[17]</xref>&#x000a0;Smoking may exacerbate the condition, with nicotine implicated in increasing follicular plugging.<xref ref-type="bibr" rid="article-22863.r18">[18]</xref><xref ref-type="bibr" rid="article-22863.r19">[19]</xref>&#x000a0;As with obesity, disease progression and severity are worse in people who smoke.<xref ref-type="bibr" rid="article-22863.r20">[20]</xref></p>
        <p>Hormonal influences,&#x000a0;signified by a higher female preponderance,&#x000a0;menstrual cycle-related symptom fluctuations, exogenous hormone intake, and pubertal and menopausal links, have been observed.<xref ref-type="bibr" rid="article-22863.r21">[21]</xref><xref ref-type="bibr" rid="article-22863.r22">[22]</xref>&#x000a0;Other potential factors include medications, bacteria, and mechanical friction.<xref ref-type="bibr" rid="article-22863.r23">[23]</xref></p>
      </sec>
      <sec id="article-22863.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The estimated prevalence of hidradenitis suppurativa ranges from under 1% to 4%.<xref ref-type="bibr" rid="article-22863.r24">[24]</xref> These numbers are likely underestimated because of underreporting and misdiagnosis.&#x000a0;The condition's onset is commonly between puberty and 40 years, most frequently from ages 21 to 29. Women are about&#x000a0;3 times more affected than men.<xref ref-type="bibr" rid="article-22863.r25">[25]</xref>&#x000a0;Racial or ethnic predilection is currently unsupported,&#x000a0;though the disease&#x000a0;may be underreported, and studies&#x000a0;have likely excluded black and Hispanic patients.<xref ref-type="bibr" rid="article-22863.r26">[26]</xref><xref ref-type="bibr" rid="article-22863.r27">[27]</xref></p>
      </sec>
      <sec id="article-22863.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hidradenitis suppurativa's pathophysiologic mechanism starts with a defective hair follicle's occlusion and rupture, releasing keratin and bacteria into the surrounding dermis. This occlusion leads to keratinocyte proliferation and an immune response.<xref ref-type="bibr" rid="article-22863.r28">[28]</xref><xref ref-type="bibr" rid="article-22863.r29">[29]</xref>&#x000a0;Neutrophilic and lymphocytic proliferation and heightened activity result in abscess formation and follicular destruction, with the involvement of adjacent tissues.<xref ref-type="bibr" rid="article-22863.r30">[30]</xref>&#x000a0;Additional contributors may include abnormal antimicrobial peptides, epidermal invaginations forming tracts, hormonal effects on follicular receptors, and complement pathways.&#x000a0;Sebaceous glands also become deficient.<xref ref-type="bibr" rid="article-22863.r31">[31]</xref><xref ref-type="bibr" rid="article-22863.r32">[32]</xref></p>
        <p>Immunological abnormalities are evident in hidradenitis suppurativa. Inflammatory cytokines like tumor necrosis factor-&#x003b1; and interleukins are elevated in lesions, offering potential treatment targets.<xref ref-type="bibr" rid="article-22863.r33">[33]</xref><xref ref-type="bibr" rid="article-22863.r34">[34]</xref><xref ref-type="bibr" rid="article-22863.r35">[35]</xref>&#x000a0;While bacteria are not considered the primary cause, these organisms may trigger an inflammatory response. Patients may receive antibiotics for presumed infections, potentially leading to drug-resistant skin flora.<xref ref-type="bibr" rid="article-22863.r36">[36]</xref>&#x000a0;Aspirates from unruptured lesions typically yield sterile cultures. Bacterial infection and colonization&#x000a0;may&#x000a0;worsen hidradenitis suppurativa.</p>
      </sec>
      <sec id="article-22863.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Hidradenitis suppurativa&#x000a0;may be diagnosed clinically,&#x000a0;but a skin biopsy&#x000a0;can help confirm&#x000a0;the diagnosis&#x000a0;in&#x000a0;equivocal cases. Hidradenitis suppurativa's histopathological features include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Follicular occlusion</p>
          </list-item>
          <list-item>
            <p>Follicular hyperkeratosis</p>
          </list-item>
          <list-item>
            <p>Infundibular follicular epithelial hyperplasia</p>
          </list-item>
          <list-item>
            <p>Epidermal psoriasiform hyperplasia</p>
          </list-item>
          <list-item>
            <p>Keratin plugging</p>
          </list-item>
          <list-item>
            <p>Perifolliculitis (predominantly lymphocytic)</p>
          </list-item>
          <list-item>
            <p>Plasmocytic infiltrate</p>
          </list-item>
          <list-item>
            <p>Pseudoepitheliomatous hyperplasia</p>
          </list-item>
        </list>
        <p>Reports on the frequency of finding foreign body and epithelioid granulomas are&#x000a0;conflicting, with some reporting them as frequent and others as infrequent. Eosinophils may be observed, but this finding is controversial, as studies report&#x000a0;eosinophilic presence&#x000a0;inconsistently.<xref ref-type="bibr" rid="article-22863.r37">[37]</xref></p>
      </sec>
      <sec id="article-22863.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Hidradenitis suppurativa diagnosis is often delayed by an average of 7 years due to its resemblance to other conditions. Clinical diagnosis involves recognizing characteristic morphological features (nodules, tunnels, and scars), location (intertriginous areas), and chronicity.<xref ref-type="bibr" rid="article-22863.r38">[38]</xref>&#x000a0;Half of patients present prodromal symptoms such as burning, stinging, pain, pruritus, warmth, or hyperhidrosis,&#x000a0;which&#x000a0;may precede lesion appearance by 12 to 48 hours.<xref ref-type="bibr" rid="article-22863.r39">[39]</xref>&#x000a0;Triggers include menstruation, weight gain, stress, hormonal changes, excessive heat, and perspiration.<xref ref-type="bibr" rid="article-22863.r40">[40]</xref>&#x000a0;Individuals are usually well-appearing and afebrile at presentation unless secondary infection or advanced disease is present.</p>
        <p>Characteristic primary hidradenitis suppurativa lesions are deep-seated nodules, typically 0.5 to 2 cm in size,&#x000a0;persisting&#x000a0;for days to months. The lesions are often mistaken for furuncles or boils and may&#x000a0;have serosanguinous discharge, which can become purulent and malodorous. Unlike furuncles, these nodules are deep, recurrent, rupture-prone, and can form intercommunicating tunnels and tracts that may ulcerate or drain.&#x000a0;Lidocaine injection or ultrasound examination can&#x000a0;help visualize these tracts.<xref ref-type="bibr" rid="article-22863.r41">[41]</xref>&#x000a0;Advanced stages may feature thick fibrotic scars and plaques, causing architectural distortion and open comedones known as "tombstone" comedones.<xref ref-type="bibr" rid="article-22863.r42">[42]</xref></p>
        <p>The axilla is the most common location for hidradenitis suppurativa lesions. Other common areas&#x000a0;include the inguinal, inner thigh, perianal, perineal, inframammary, gluteal, pubic, scrotal, vulvar, and trunk regions.&#x000a0;The scalp and retroauricular areas are less frequently involved (see&#x000a0;<bold>Image</bold>.&#x000a0;Hidradenitis Suppurativa, Groin).<xref ref-type="bibr" rid="article-22863.r43">[43]</xref>&#x000a0;Pertinent history includes onset typically from puberty to young adulthood, with recurrent lesions and intermittent improvement. A family history of a similar condition aids in diagnosis confirmation.</p>
        <p>Once the history and physical exam are complete, the Hurley staging system&#x000a0;may&#x000a0;be used to&#x000a0;classify the disease. This system categorizes lesions as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hurley Stage I: Abscesses&#x000a0;lack&#x000a0;tunnels&#x000a0;and&#x000a0;scars.</p>
          </list-item>
          <list-item>
            <p>Hurley Stage II: Recurrent abscesses&#x000a0;have&#x000a0;tunnels and scars,&#x000a0;and the lesions&#x000a0;may be single or multiple but widely separated.</p>
          </list-item>
          <list-item>
            <p>Hurley Stage III: Lesions&#x000a0;diffusely involve&#x000a0;the skin,&#x000a0;ie, multiple interconnected sinus tracts are present, and abscesses&#x000a0;occupy&#x000a0;large&#x000a0;areas, leaving little to no uninvolved skin (see&#x000a0;<bold>Image</bold>.&#x000a0;Hidradenitis Suppurativa, Suprapubic Region).&#x000a0;<xref ref-type="bibr" rid="article-22863.r44">[44]</xref></p>
          </list-item>
        </list>
        <p>Hidradenitis suppurativa is&#x000a0;a component of the follicular occlusion tetrad, along with acne conglobata, dissecting scalp cellulitis, and pilonidal sinus.<xref ref-type="bibr" rid="article-22863.r45">[45]</xref>&#x000a0;A diagnosis of hidradenitis suppurativa should prompt evaluation for&#x000a0;possible cooccurrence of these conditions. Clinicians should also consider associations with metabolic syndrome, dyslipidemia, hypertension, diabetes mellitus, inflammatory bowel disease (especially Crohn disease), and spondyloarthropathy during assessment.<xref ref-type="bibr" rid="article-22863.r46">[46]</xref>&#x000a0;Syndromes like pyogenic arthritis, pyoderma gangrenosum, acne, suppurative hidradenitis (PAPASH) and pyoderma gangrenosum, acne suppurative hidradenitis (PASH), possibly&#x000a0;related to a&#x000a0;<italic toggle="yes">PSTPIP1</italic>&#x000a0;gene mutation, also warrant attention.<xref ref-type="bibr" rid="article-22863.r47">[47]</xref></p>
      </sec>
      <sec id="article-22863.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Hidradenitis suppurativa is a clinical diagnosis. No biological or pathological diagnostic tests are required to confirm the condition. However, a biopsy may help&#x000a0;rule out squamous cell carcinoma if the diagnosis is uncertain. Bacterial cultures are not&#x000a0;beneficial&#x000a0;unless a secondary infection or an alternative diagnosis is suspected. Imaging is not typically helpful, though&#x000a0;ultrasonography&#x000a0;may&#x000a0;help identify skin tunneling&#x000a0;preoperatively.<xref ref-type="bibr" rid="article-22863.r48">[48]</xref>&#x000a0;Severe perianal disease may warrant further imaging, preferably by magnetic resonance imaging.<xref ref-type="bibr" rid="article-22863.r49">[49]</xref>&#x000a0;</p>
        <p>Guidelines recommend additional investigations to assess comorbid conditions in patients with hidradenitis suppurativa. Assessments typically involve annual physical examinations, validated screening tools,&#x000a0;and laboratory tests. Referrals to specialists familiar with associated conditions may be necessary for further evaluation. Comorbidities in patients with hidradenitis suppurativa may include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acne vulgaris or acne conglobata</p>
          </list-item>
          <list-item>
            <p>Dissecting cellulitis of the scalp</p>
          </list-item>
          <list-item>
            <p>Pilonidal cyst</p>
          </list-item>
          <list-item>
            <p>Pyoderma gangrenosum</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Anxiety</p>
          </list-item>
          <list-item>
            <p>Suicidality</p>
          </list-item>
          <list-item>
            <p>Tobacco use disorder</p>
          </list-item>
          <list-item>
            <p>Substance use disorder</p>
          </list-item>
          <list-item>
            <p>Polycystic ovarian syndrome</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Dyslipidemia</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus</p>
          </list-item>
          <list-item>
            <p>Metabolic syndrome</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Cardiovascular disease</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>SAPHO syndrome</p>
          </list-item>
          <list-item>
            <p>Behcet syndrome</p>
          </list-item>
          <list-item>
            <p>Spondyloarthritis</p>
          </list-item>
          <list-item>
            <p>Sexual dysfunction</p>
          </list-item>
          <list-item>
            <p>Down syndrome</p>
          </list-item>
          <list-item>
            <p>Thyroid disease</p>
          </list-item>
          <list-item>
            <p>Nonalcoholic fatty liver disease</p>
          </list-item>
          <list-item>
            <p>Obstructive sleep apnea</p>
          </list-item>
          <list-item>
            <p>Renal disease</p>
          </list-item>
          <list-item>
            <p>Sleep disturbances</p>
          </list-item>
          <list-item>
            <p>Alzheimer disease</p>
          </list-item>
          <list-item>
            <p>Herpes zoster</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Psoriasis vulgaris</p>
          </list-item>
          <list-item>
            <p>Pachyonychia congenita</p>
          </list-item>
          <list-item>
            <p>Dowling-Degos disease</p>
          </list-item>
          <list-item>
            <p>KID syndrome</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Anemia</p>
          </list-item>
          <list-item>
            <p>Cutaneous squamous cell carcinoma&#x000a0;:<xref ref-type="bibr" rid="article-22863.r50">[50]</xref><xref ref-type="bibr" rid="article-22863.r51">[51]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22863.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The overall treatment goals for hidradenitis suppurativa include alleviating lesion-related symptoms (eg, pain), reducing recurrence frequency and new lesion formation, and preventing disease and comorbidity progression.&#x000a0;Treatment approaches are largely based on expert opinion and consensus&#x000a0;due to limited comparative studies.</p>
        <p>Treatment response assessment involves monitoring lesion frequency, severity, extent, and morphology.&#x000a0;Quality of life changes are also evaluated using validated tools, and progression to associated comorbidities is assessed. Various scales and scoring systems, including the International Hidradenitis Suppurativa Severity Scoring System, Sartorius score,&#x000a0;Hidradenitis&#x000a0;Suppurativa&#x000a0;Physician&#x000a0;Global&#x000a0;Assessment, and&#x000a0;Hidradenitis&#x000a0;Suppurativa&#x000a0;Core&#x000a0;Outcome&#x000a0;Set&#x000a0;International&#x000a0;Collaboration, are used to measure&#x000a0;the condition's severity and treatment outcomes.<xref ref-type="bibr" rid="article-22863.r52">[52]</xref><xref ref-type="bibr" rid="article-22863.r53">[53]</xref><xref ref-type="bibr" rid="article-22863.r54">[54]</xref></p>
        <p>Hidradenitis suppurativa&#x000a0;treatment should address comorbidities contributing to disease development or worsening, regardless of disease stage. Counseling and support for weight loss and smoking cessation are crucial, as obesity and smoking are associated with more severe disease progression. Minimizing skin trauma is also essential, achieved by avoiding tight clothing, harsh cleaning products, and adhesive dressings. Soft dressings with clear petroleum jelly or nonocclusive dressings can help prevent further irritation to draining lesions.<xref ref-type="bibr" rid="article-22863.r55">[55]</xref></p>
        <p>Patients with hidradenitis suppurativa should&#x000a0;be thoroughly&#x000a0;educated&#x000a0;about&#x000a0;the condition's nature, wound care, and pain management. Individualized pain management plans must address potential inpatient admissions.<xref ref-type="bibr" rid="article-22863.r56">[56]</xref><xref ref-type="bibr" rid="article-22863.r57">[57]</xref>&#x000a0;Hidradenitis suppurativa-related pain stems from both inflammatory and noninflammatory sources,&#x000a0;including scarring&#x000a0;(causing tensile pain), keloids, abscesses, open ulcerations, sinus tracts, frictional pain, lymphedema, anal fissures, and arthritis. Treatments may include topical agents like lidocaine, systemic nonsteroidal anti-inflammatory drugs, acetaminophen, atypical anticonvulsants such as gabapentin or pregabalin, and serotonin-norepinephrine reuptake inhibitors, depending on disease severity and pain type. Duloxetine may be particularly beneficial for patients with comorbid depression.<xref ref-type="bibr" rid="article-22863.r58">[58]</xref><xref ref-type="bibr" rid="article-22863.r59">[59]</xref></p>
        <p>A critically important but often overlooked aspect of treatment involves hidradenitis suppurativa's psychosocial aspect. Pain, drainage, odor, and involvement of sensitive areas reduce patients' quality of life.<xref ref-type="bibr" rid="article-22863.r60">[60]</xref>&#x000a0;Individuals&#x000a0;with&#x000a0;this condition may experience social isolation, employment&#x000a0;difficulties due to missed work during flares, and heightened sexual or relationship dysfunction.<xref ref-type="bibr" rid="article-22863.r61">[61]</xref>&#x000a0;Assurance that this condition is not contagious or the result of&#x000a0;poor hygiene can be helpful. Counseling and support groups are often beneficial additions to therapeutic plans.<xref ref-type="bibr" rid="article-22863.r62">[62]</xref>&#x000a0;Treatment for acute symptomatic lesions may include intralesional corticosteroid injection (usually triamcinolone), punch debridement,&#x000a0;and topical resorcinol.<xref ref-type="bibr" rid="article-22863.r63">[63]</xref><xref ref-type="bibr" rid="article-22863.r64">[64]</xref><xref ref-type="bibr" rid="article-22863.r65">[65]</xref>&#x000a0;Incision and drainage is not recommended.<xref ref-type="bibr" rid="article-22863.r66">[66]</xref></p>
        <p>Topical antibiotics are the first-line treatment for early uncomplicated disease.&#x000a0;Topical clindamycin has been proven the most effective&#x000a0;and may&#x000a0;be an appropriate adjunctive treatment to oral therapy.<xref ref-type="bibr" rid="article-22863.r67">[67]</xref>&#x000a0;Hurley stage I disease&#x000a0;without skin tunneling or scarring&#x000a0;may be treated with oral tetracycline antibiotics (eg, doxycycline), antiandrogen agents (eg, spironolactone),&#x000a0;and metformin.<xref ref-type="bibr" rid="article-22863.r68">[68]</xref>&#x000a0;Tetracyclines should be discontinued and other agents retained if&#x000a0;patient&#x000a0;response is satisfactory after 2 to 3 months.&#x000a0;Another tetracycline&#x000a0;trial should be initiated if improvement occurs but is unsatisfactory. Switching to a combination of oral clindamycin and rifampin, dapsone, or acitretin may be&#x000a0;considered if the clinical response remains unsatisfactory after 2 to 3 months on the same regimen or a&#x000a0;2nd tetracycline&#x000a0;trial.<xref ref-type="bibr" rid="article-22863.r69">[69]</xref><xref ref-type="bibr" rid="article-22863.r70">[70]</xref></p>
        <p>The initial treatment for Hurley stages II and III is similar to that of Hurley stage I disease.&#x000a0;Potential treatment reactions must be considered during therapeutic planning.&#x000a0;Patients&#x000a0;should be educated on these medications' adverse effects&#x000a0;before starting their regimen.</p>
        <p>Surgical&#x000a0;or biologic therapy should be considered if the patient poorly responds after 2 to 3 months of initial therapy,&#x000a0;fails a 2- to 3-month second therapeutic trial, or a Hurley stage I case is treatment-refractory.<xref ref-type="bibr" rid="article-22863.r71">[71]</xref></p>
        <p>The preferred biologic agent for hidradenitis suppurativa is adalimumab, as it is backed by extensive research. Secukinumab, infliximab, or acitretin are alternatives.&#x000a0;Etanercept has not shown efficacy in treating this condition.<xref ref-type="bibr" rid="article-22863.r72">[72]</xref><xref ref-type="bibr" rid="article-22863.r73">[73]</xref><xref ref-type="bibr" rid="article-22863.r74">[74]</xref>&#x000a0;The treatment must be continued if the patient demonstrates&#x000a0;progressive improvement after 3 to 4 months of biologic therapy. Oral antiandrogen agents and metformin may be used as adjuncts.<xref ref-type="bibr" rid="article-22863.r75">[75]</xref></p>
        <p>Switching to a different class of biologics is advised if the response is unsatisfactory,&#x000a0;followed by&#x000a0;reassessment&#x000a0;in 3 to 4 months for continued treatment or consideration of alternatives.<xref ref-type="bibr" rid="article-22863.r76">[76]</xref><xref ref-type="bibr" rid="article-22863.r77">[77]</xref>&#x000a0;Surgical management and adjunctive therapies like intravenous ertapenem may be considered for severe, refractory hidradenitis suppurativa. Localized laser and pulsed light therapy may be offered as an option&#x000a0;to disrupt the inflammatory process.<xref ref-type="bibr" rid="article-22863.r78">[78]</xref><xref ref-type="bibr" rid="article-22863.r79">[79]</xref><xref ref-type="bibr" rid="article-22863.r80">[80]</xref></p>
        <p>Surgical management may be pursued at any stage to remove areas of active disease and limit complications, but it should be combined with&#x000a0;medical therapy.&#x000a0;Preoperative management should include antibiotics, anti-inflammatory&#x000a0;agents (eg, biologics or cyclosporine), and&#x000a0;corticosteroids (eg, prednisone or glucocorticoids).<xref ref-type="bibr" rid="article-22863.r81">[81]</xref>&#x000a0;Local procedures include punch debridement, deroofing, or wide excision. Punch debridement uses a 5- to 7-mm&#x000a0;circular punch biopsy tool to evacuate an inflamed lesion.&#x000a0;The lesion is left to heal by secondary intention with a petrolatum dressing&#x000a0;after achieving hemostasis.&#x000a0;Deroofing involves entering skin tunnels and sequentially removing their roofs using scissors or a carbon dioxide laser.<xref ref-type="bibr" rid="article-22863.r82">[82]</xref></p>
        <p>Wide excision with reconstruction may be&#x000a0;performed&#x000a0;to debride a lesion&#x000a0;until&#x000a0;only the subcutaneous fat remains. Primary closure or a larger flap&#x000a0;may be used for repair, depending on the anatomic location.<xref ref-type="bibr" rid="article-22863.r83">[83]</xref>&#x000a0;Grafting, which involves debriding the affected subepidermal skin and recycling the epidermis as a skin graft, may also be considered. Negative pressure wound therapy has also been used.<xref ref-type="bibr" rid="article-22863.r84">[84]</xref>&#x000a0;Petrolatum&#x000a0;nonadherent dressings&#x000a0;are recommended&#x000a0;postoperatively to avoid friction.&#x000a0;However,&#x000a0;patients should be cautioned about the risks of bleeding, infection, or new disease when using these dressings.<xref ref-type="bibr" rid="article-22863.r85">[85]</xref></p>
        <p>Other therapies that may be considered include neodymium-doped yttrium aluminum garnet (Nd:YAG)&#x000a0;laser, ustekinumab, anakinra, bimekizumab, guselkumab, canakinumab, cyclosporine, tacrolimus, apremilast, zinc, photodynamic therapy, golimumab, risankizumab, liraglutide, microwave ablation (not currently recommended), cryoinsufflation, botulinum toxin injections, and ionizing radiation.</p>
      </sec>
      <sec id="article-22863.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The&#x000a0;following conditions should be ruled out&#x000a0;when diagnosing hidradenitis suppurativa:</p>
        <list list-type="bullet">
          <list-item>
            <p>Follicular pyoderma (including folliculitis, furuncles, and&#x000a0;carbuncles)</p>
          </list-item>
          <list-item>
            <p>Granuloma inguinale</p>
          </list-item>
          <list-item>
            <p>Noduloulcerative syphilis</p>
          </list-item>
          <list-item>
            <p>Tuberculous abscess</p>
          </list-item>
          <list-item>
            <p>Actinomycosis</p>
          </list-item>
          <list-item>
            <p>Lymphogranuloma venereum</p>
          </list-item>
          <list-item>
            <p>Acne vulgaris&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epidermoid, dermoid, pilonidal, or Bartholin cysts</p>
          </list-item>
          <list-item>
            <p>Crohn&#x000a0;disease (particularly with perianal involvement)</p>
          </list-item>
        </list>
        <p>The following conditions should also be included in the differential diagnosis&#x000a0;due to similar&#x000a0;histopathology:</p>
        <list list-type="bullet">
          <list-item>
            <p>Granulomatous diseases (Crohn&#x000a0;disease, sarcoidosis,&#x000a0;mycobacterial infection)</p>
          </list-item>
          <list-item>
            <p>Chronic deep folliculitis</p>
          </list-item>
          <list-item>
            <p>Langerhans cell histiocytosis</p>
          </list-item>
          <list-item>
            <p>Folliculotropic mycosis fungoides</p>
          </list-item>
          <list-item>
            <p>Crohn disease</p>
          </list-item>
          <list-item>
            <p>Pyoderma gangrenosum</p>
          </list-item>
          <list-item>
            <p>Follicular rupture</p>
          </list-item>
          <list-item>
            <p>Abscess&#x000a0;<xref ref-type="bibr" rid="article-22863.r86">[86]</xref><xref ref-type="bibr" rid="article-22863.r87">[87]</xref><xref ref-type="bibr" rid="article-22863.r88">[88]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22863.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of&#x000a0;hidradenitis suppurativa is variable.&#x000a0;The condition&#x000a0;is incurable and&#x000a0;has a chronic, relapsing course.<xref ref-type="bibr" rid="article-22863.r89">[89]</xref>&#x000a0;Diagnostic and treatment delays early in the disease course and comorbid conditions&#x000a0;like smoking and obesity&#x000a0;often worsen the prognosis.<xref ref-type="bibr" rid="article-22863.r90">[90]</xref>&#x000a0;Hurley stage III disease has the worst prognosis, but early recognition can help prevent complications.</p>
      </sec>
      <sec id="article-22863.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Hidradenitis suppurativa has both physical and psychological&#x000a0;complications.<xref ref-type="bibr" rid="article-22863.r91">[91]</xref>&#x000a0;Hidradenitis suppurativa&#x000a0;recurrence&#x000a0;may result in chronic pain, limb contractures, and impaired mobility from abscesses, tunnels, and scarring. Lymphatic obstruction may cause peripheral lymphedema.<xref ref-type="bibr" rid="article-22863.r92">[92]</xref> Chronic inflammation's&#x000a0;long-term effects&#x000a0;include anemia, hyperproteinemia, amyloidosis, and axial and peripheral arthropathy.<xref ref-type="bibr" rid="article-22863.r93">[93]</xref> Superimposed infections&#x000a0;may result in systemic illness.&#x000a0;Squamous cell carcinoma may develop, sometimes&#x000a0;up to 30 years after diagnosis.<xref ref-type="bibr" rid="article-22863.r94">[94]</xref></p>
        <p>Observational data suggests an increased risk of buccal and hepatocellular cancer.<xref ref-type="bibr" rid="article-22863.r95">[95]</xref>&#x000a0;Hidradenitis suppurativa's psychological impact includes depression, social isolation, decreased relationship satisfaction, sexual dysfunction, reduced work productivity, and in extreme cases, suicide.</p>
      </sec>
      <sec id="article-22863.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education should include reassuring individuals that&#x000a0;hidradenitis suppurativa&#x000a0;is not contagious or due to poor hygiene. Prompt reporting of lesions is advised to initiate timely treatment and prevent chronic progression . Lifestyle modifications, such as maintaining a healthy weight, quitting smoking, and avoiding skin trauma&#x000a0;(eg, by avoiding tight clothing, abrasive cleansers, and adhesive bandages), should be discussed. Patients should also receive information on the risks and benefits of available treatments, with the&#x000a0;most effective therapy for their current disease state recommended. Psychosocial education and treatment are likewise essential components of care.</p>
      </sec>
      <sec id="article-22863.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Hidradenitis suppurativa is a non-contagious chronic inflammatory skin disorder characterized by painful nodules, abscesses, and scarring. The condition starts to develop&#x000a0;with hair follicle blockage, followed by rupture and inflammation.&#x000a0;Hidradenitis suppurativa is not caused by infection or poor hygiene. Genetic and environmental elements contribute to its pathophysiology, with obesity and smoking being key factors.</p>
        <p>Treatment options include medications (topical and oral antibiotics, intralesional and oral steroids, hormone therapy, and immune modulators) and surgery, ranging from lesion deroofing to wide excision. Hidradenitis suppurativa can cause significant psychosocial distress due to pain, drainage, odor, and&#x000a0;involvement of&#x000a0;sensitive or exposed areas. Early recognition and aggressive treatment offer the best prognosis, including psychosocial support.</p>
      </sec>
      <sec id="article-22863.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hidradenitis suppurativa is a complex condition with numerous comorbidities, requiring an interprofessional approach for effective management.<xref ref-type="bibr" rid="article-22863.r96">[96]</xref>&#x000a0;While&#x000a0;this disorder is primarily a dermatologic concern, individuals may first seek care from various healthcare providers, such as family medicine, internal medicine, pediatrics, or obstetrics/gynecology. Primary care providers are crucial in early recognition and treatment initiation based on lesion characteristics. Depending on disease severity and provider training, primary care providers may manage the condition independently or refer to specialists like dermatologists, surgeons, wound care, and pain management experts.</p>
        <p>The involvement of multiple healthcare team members, including professionals in the allied health sciences like nurses and pharmacists, may be necessary due to hidradenitis suppurativa's associated comorbidities. Nurses offer counseling, aid in history and examination, and&#x000a0;act as liaisons&#x000a0;between patients and clinicians. Pharmacists ensure correct dosing, check for interactions, and educate patients on medication use.&#x000a0;Mental health providers should be part of the team, including psychiatrists, psychologists, or counselors,&#x000a0;given the condition's significant psychosocial impact.&#x000a0;Accurate documentation by all team members is crucial for consistent patient care. Open communication is essential for addressing any issues promptly. This interprofessional approach enhances patient outcomes.</p>
      </sec>
      <sec id="article-22863.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22863&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22863">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22863/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22863">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22863.s17">
        <fig id="article-22863.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Hidradenitis Suppurativa, Left Axilla. Multiple nodules and fibrotic scars are seen in the left axilla. Contributed by S Verma, MBBS, DVD, FRCP, FAAD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hidradenitis__suppurativa__SV1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22863.s18">
        <fig id="article-22863.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Hidradenitis Suppurativa, Groin. Nodules and scarring are distributed in the groin area. Contributed by S Verma, MBBS, DVD, FRCP, FAAD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Hidradenitis__suppurativa__SV2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22863.s19">
        <fig id="article-22863.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Hidradenitis Suppurativa, Suprapubic Region. Nodules and scarring are distributed in the suprapubic area. Contributed by S Verma, MBBS, DVD, FRCP, FAAD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hidradenitis__suppurativa__SV2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22863.s20">
        <title>References</title>
        <ref id="article-22863.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez-L&#x000f3;pez</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa.</article-title>
            <source>Med Clin (Barc)</source>
            <year>2024</year>
            <month>Feb</month>
            <day>23</day>
            <volume>162</volume>
            <issue>4</issue>
            <fpage>182</fpage>
            <page-range>182-189</page-range>
            <pub-id pub-id-type="pmid">37968174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stancic</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Boer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dolenc-Volj&#x0010d;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GBE</given-names>
              </name>
            </person-group>
            <article-title>The Role of Intra-Follicular Shear Forces in Hidradenitis Suppurativa.</article-title>
            <source>Skin Pharmacol Physiol</source>
            <year>2023</year>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>302</fpage>
            <page-range>302-303</page-range>
            <pub-id pub-id-type="pmid">38176392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mintoff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study.</article-title>
            <source>Hum Immunol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>110764</fpage>
            <pub-id pub-id-type="pmid">38320910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scala</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cacciapuoti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garzorz-Stark</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Megna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marasca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seiringer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Volz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eyerich</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fabbrocini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa: Where We Are and Where We Are Going.</article-title>
            <source>Cells</source>
            <year>2021</year>
            <month>Aug</month>
            <day>15</day>
            <volume>10</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">34440863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gillern</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of Pilonidal Disease and Hidradenitis Suppurativa.</article-title>
            <source>Surg Clin North Am</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>104</volume>
            <issue>3</issue>
            <fpage>503</fpage>
            <page-range>503-515</page-range>
            <pub-id pub-id-type="pmid">38677816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seivright</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Collier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hogeling</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>2391</fpage>
            <page-range>2391-2393</page-range>
            <pub-id pub-id-type="pmid">34057384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirby</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zivkovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Danavar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach.</article-title>
            <source>Front Med Technol</source>
            <year>2024</year>
            <volume>6</volume>
            <fpage>1200400</fpage>
            <pub-id pub-id-type="pmid">38591045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Yousef</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miao</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Alhajj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Badri</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <chapter-title>Histology, Skin Appendages</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">29489291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodruff</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Charlie</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa: A Guide for the Practicing Physician.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>90</volume>
            <issue>12</issue>
            <fpage>1679</fpage>
            <page-range>1679-93</page-range>
            <pub-id pub-id-type="pmid">26653298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bali&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marinovi&#x00107;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bukvi&#x00107; Mokos</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>The genetic aspects of hidradenitis suppurativa.</article-title>
            <source>Clin Dermatol</source>
            <year>2023</year>
            <season>Sep-Oct</season>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>551</fpage>
            <page-range>551-563</page-range>
            <pub-id pub-id-type="pmid">37652193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brand&#x000e3;o</surname>
                <given-names>LAC</given-names>
              </name>
              <name>
                <surname>Tricarico</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gratton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agrelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zupin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Abou-Saleh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crovella</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Feb</month>
            <day>03</day>
            <volume>22</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">33546374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morales-Heil</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Malara</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Milam</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Anadkat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaffenberger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaffenberger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nagele</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Roberson</surname>
                <given-names>EDO</given-names>
              </name>
            </person-group>
            <article-title>Rare missense variants in the SH3 domain of <italic>PSTPIP1</italic> are associated with hidradenitis suppurativa.</article-title>
            <source>HGG Adv</source>
            <year>2023</year>
            <month>Apr</month>
            <day>13</day>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>100187</fpage>
            <pub-id pub-id-type="pmid">37013170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tricarico</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gratton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dos Santos-Silva</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>de Moura</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ura</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sommella</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Campiglia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Del Vecchio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moltrasio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Berti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>D'Adamo</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Elsherbini</surname>
                <given-names>AMA</given-names>
              </name>
              <name>
                <surname>Staudenmaier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chersi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Boniotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krismer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schittek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Crovella</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>1060547</fpage>
            <pub-id pub-id-type="pmid">36544771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Broadaway</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Edmiston</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Fajgenbaum</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miller-Fleming</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Westerkam</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Melendez-Gonzalez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Levitt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mohlke</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Sayed</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Genetic Variants Associated With Hidradenitis Suppurativa.</article-title>
            <source>JAMA Dermatol</source>
            <year>2023</year>
            <month>Sep</month>
            <day>01</day>
            <volume>159</volume>
            <issue>9</issue>
            <fpage>930</fpage>
            <page-range>930-938</page-range>
            <pub-id pub-id-type="pmid">37494057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment.</article-title>
            <source>Biomedicines</source>
            <year>2024</year>
            <month>Feb</month>
            <day>01</day>
            <volume>12</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">38397941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GBE</given-names>
              </name>
            </person-group>
            <article-title>Mechanical forces and Hidradenitis Suppurativa.</article-title>
            <source>Exp Dermatol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-215</page-range>
            <pub-id pub-id-type="pmid">33155312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zouboulis</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.</article-title>
            <source>Pharmaceutics</source>
            <year>2021</year>
            <month>Dec</month>
            <day>26</day>
            <volume>14</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">35056940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ralser</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Basmanav</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Tafazzoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wititsuwannakul</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Delker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Danda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pulimood</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Altm&#x000fc;ller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000fc;rnberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hillen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Wenzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Odermatt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Betz</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Mutations in &#x003b3;-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.</article-title>
            <source>J Clin Invest</source>
            <year>2017</year>
            <month>Apr</month>
            <day>03</day>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>1485</fpage>
            <page-range>1485-1490</page-range>
            <pub-id pub-id-type="pmid">28287404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bukvi&#x00107; Mokos</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mi&#x00161;e</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bali&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marinovi&#x00107;</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Understanding the Relationship Between Smoking and Hidradenitis Suppurativa.</article-title>
            <source>Acta Dermatovenerol Croat</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-13</page-range>
            <pub-id pub-id-type="pmid">32650845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vossen</surname>
                <given-names>ARJV</given-names>
              </name>
              <name>
                <surname>van Straalen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Swolfs</surname>
                <given-names>EFH</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Ardon</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>van der Zee</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa.</article-title>
            <source>Dermatology</source>
            <year>2021</year>
            <volume>237</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <page-range>383-385</page-range>
            <pub-id pub-id-type="pmid">33535209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nowak-Liduk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kitala</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ocha&#x00142;a-Gierek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>&#x00141;abu&#x0015b;</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bergler-Czop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pietrauszka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Niemiec</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Szyluk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gierek</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.</article-title>
            <source>Life (Basel)</source>
            <year>2023</year>
            <month>Sep</month>
            <day>11</day>
            <volume>13</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">37763299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa: Disease pathophysiology and sex hormones.</article-title>
            <source>Chin J Physiol</source>
            <year>2021</year>
            <season>Nov-Dec</season>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>257</fpage>
            <page-range>257-265</page-range>
            <pub-id pub-id-type="pmid">34975118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kisule</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kak</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Alamelumangapuram</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Drug-Induced Hidradenitis Suppurativa: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>e49637</fpage>
            <pub-id pub-id-type="pmid">38161925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jfri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nassim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gulliver</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nikolakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.</article-title>
            <source>JAMA Dermatol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>157</volume>
            <issue>8</issue>
            <fpage>924</fpage>
            <page-range>924-931</page-range>
            <pub-id pub-id-type="pmid">34037678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinikumpu</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Jokelainen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huilaja</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2024</year>
            <month>Jan</month>
            <day>10</day>
            <volume>104</volume>
            <fpage>adv14732</fpage>
            <pub-id pub-id-type="pmid">38197699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>McAndrew</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hamzavi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa.</article-title>
            <source>Dermatol Clin</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-16</page-range>
            <pub-id pub-id-type="pmid">26617352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greif</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kimball</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Holcomb</surname>
                <given-names>ZE</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis.</article-title>
            <source>Int J Womens Dermatol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>e129</fpage>
            <pub-id pub-id-type="pmid">38240009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Straalen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Prens</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Gudjonsson</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Insights into hidradenitis suppurativa.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>149</volume>
            <issue>4</issue>
            <fpage>1150</fpage>
            <page-range>1150-1161</page-range>
            <pub-id pub-id-type="pmid">35189127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brandao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tricarico</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gratton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Genovese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moltrasio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcovich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boniotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crovella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach.</article-title>
            <source>J Dermatol Sci</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">32518053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Deckers</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of hidradenitis suppurativa: An update.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>73</volume>
            <issue>5 Suppl 1</issue>
            <fpage>S8</fpage>
            <page-range>S8-11</page-range>
            <pub-id pub-id-type="pmid">26470623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Laffert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stadie</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wohlrab</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marsch</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae.</article-title>
            <source>Br J Dermatol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>164</volume>
            <issue>2</issue>
            <fpage>367</fpage>
            <page-range>367-71</page-range>
            <pub-id pub-id-type="pmid">20831631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Zee</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Laman</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Boer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prens</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.</article-title>
            <source>Exp Dermatol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>735</fpage>
            <page-range>735-9</page-range>
            <pub-id pub-id-type="pmid">22882284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brembach</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Sabat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schwerdtle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wolk</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation.</article-title>
            <source>Front Immunol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1281685</fpage>
            <pub-id pub-id-type="pmid">38077313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa.</article-title>
            <source>Br J Dermatol</source>
            <year>2023</year>
            <month>Nov</month>
            <day>16</day>
            <volume>189</volume>
            <issue>6</issue>
            <fpage>719</fpage>
            <page-range>719-729</page-range>
            <pub-id pub-id-type="pmid">37540988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Podwojniak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies.</article-title>
            <source>Curr Issues Mol Biol</source>
            <year>2024</year>
            <month>Mar</month>
            <day>30</day>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>2975</fpage>
            <page-range>2975-2990</page-range>
            <pub-id pub-id-type="pmid">38666916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gierek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ocha&#x00142;a-Gierek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kitala</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>&#x00141;abu&#x0015b;</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bergler-Czop</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa: bacteriological study in surgical treatment.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>1101</fpage>
            <page-range>1101-1105</page-range>
            <pub-id pub-id-type="pmid">36686013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>SDB</given-names>
              </name>
              <name>
                <surname>Okoye</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Sokumbi</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Histopathology of Hidradenitis Suppurativa: A Systematic Review.</article-title>
            <source>Dermatopathology (Basel)</source>
            <year>2022</year>
            <month>Jul</month>
            <day>14</day>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-257</page-range>
            <pub-id pub-id-type="pmid">35892482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riva</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hendricks</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Del Coro Amengual</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maddox</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Decades Delayed in Diagnosis: Hidradenitis Suppurativa and a Review of Barriers to Care.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>e56231</fpage>
            <pub-id pub-id-type="pmid">38618324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ring</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Theut Riis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zarchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Saunte</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Prodromal symptoms in hidradenitis suppurativa.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>261</fpage>
            <page-range>261-265</page-range>
            <pub-id pub-id-type="pmid">28194809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shams</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sayed</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Patient-reported exacerbating factors for hidradenitis suppurativa: A cross sectional study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2024</year>
            <month>Mar</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">38556091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harvey</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Fortson</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>e18704</fpage>
            <pub-id pub-id-type="pmid">34790460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frew</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lowes</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piguet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ingram</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GBE</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.</article-title>
            <source>JAMA Dermatol</source>
            <year>2021</year>
            <month>Apr</month>
            <day>01</day>
            <volume>157</volume>
            <issue>4</issue>
            <fpage>449</fpage>
            <page-range>449-455</page-range>
            <pub-id pub-id-type="pmid">33688910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shahzeidi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bernhardt</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa.</article-title>
            <source>Skin Therapy Lett</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">38574201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramirez-GarciaLuna</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Yangzom</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Piguet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Use of thermal imaging and a dedicated wound-imaging smartphone app as an adjunct to staging hidradenitis suppurativa.</article-title>
            <source>Br J Dermatol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>186</volume>
            <issue>4</issue>
            <fpage>723</fpage>
            <page-range>723-726</page-range>
            <pub-id pub-id-type="pmid">34748648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Treadwell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feschuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valdebran</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Understanding patient demographics and treatment strategies observed in the follicular occlusion triad and tetrad.</article-title>
            <source>Arch Dermatol Res</source>
            <year>2024</year>
            <month>Apr</month>
            <day>04</day>
            <volume>316</volume>
            <issue>4</issue>
            <fpage>117</fpage>
            <pub-id pub-id-type="pmid">38573444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Patrick</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Sreeskandarajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahlenberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gudjonsson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tsoi</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors.</article-title>
            <source>Front Immunol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1309549</fpage>
            <pub-id pub-id-type="pmid">38259463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maronese</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Moltrasio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.</article-title>
            <source>Dermatol Clin</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-265</page-range>
            <pub-id pub-id-type="pmid">38423685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soto-Moreno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cuenca-Barrales</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arias-Santiago</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Vidal</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Medina-Mirapeix</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Molina-Leyva</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Safety and Effectiveness of Percutaneous Ultrasound-Guided Galvanic Current in Tunnels of Patients with Hidradenitis Suppurativa: A Pilot Study.</article-title>
            <source>Dermatol Ther (Heidelb)</source>
            <year>2024</year>
            <month>Apr</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">38676840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nazzaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Calzari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vaienti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Passoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>The role of imaging technologies in the diagnosis of hidradenitis suppurativa.</article-title>
            <source>Clin Dermatol</source>
            <year>2023</year>
            <season>Sep-Oct</season>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>611</fpage>
            <page-range>611-621</page-range>
            <pub-id pub-id-type="pmid">37652192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rostgaard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GBE</given-names>
              </name>
              <name>
                <surname>Hjalgrim</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Increased cancer incidence among patients with hidradenitis suppurativa - a Danish nationwide register study 1977-2017.</article-title>
            <source>Acta Oncol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>21</day>
            <volume>63</volume>
            <fpage>220</fpage>
            <page-range>220-228</page-range>
            <pub-id pub-id-type="pmid">38647025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malviya</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Strunk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alhusayen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alikhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daveluy</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Delorme</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gulliver</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hamzavi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jaleel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kimball</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kirchhof</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Lester</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lev-Tov</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lowes</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Micheletti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Orenstein</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Piguet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sayed</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2022</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>1092</fpage>
            <page-range>1092-1101</page-range>
            <pub-id pub-id-type="pmid">33493574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Review of Scoring Systems for Hidradenitis Suppurativa.</article-title>
            <source>Ann Dermatol</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-17</page-range>
            <pub-id pub-id-type="pmid">38325429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holgersen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Rosen&#x000f8;</surname>
                <given-names>NAL</given-names>
              </name>
              <name>
                <surname>Thyssen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Egeberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Ring</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa.</article-title>
            <source>JAAD Int</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>15</volume>
            <fpage>170</fpage>
            <page-range>170-178</page-range>
            <pub-id pub-id-type="pmid">38638915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastacouris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tannenbaum</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Strunk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koptyev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aarts</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alhusayen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bechara</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Benhadou</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bettoli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brassard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Choon</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Coutts</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>DLF</given-names>
              </name>
              <name>
                <surname>Daveluy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dellavalle</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Del Marmol</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Emtestam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gebauer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giamarellos-Bourboulis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hamzavi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hazen</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Horv&#x000e1;th</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ingram</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GBE</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lowes</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Matusiak</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Okun</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Oon</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Orenstein</surname>
                <given-names>LAV</given-names>
              </name>
              <name>
                <surname>Paek</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Pascual</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fernandez-Pe&#x000f1;as</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Resnik</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Sayed</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Thorlacius</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van der Zee</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>van Straalen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.</article-title>
            <source>JAMA Dermatol</source>
            <year>2023</year>
            <month>Nov</month>
            <day>01</day>
            <volume>159</volume>
            <issue>11</issue>
            <fpage>1258</fpage>
            <page-range>1258-1266</page-range>
            <pub-id pub-id-type="pmid">37755725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alikhan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Topical management and wound care approaches for hidradenitis suppurativa.</article-title>
            <source>Semin Cutan Med Surg</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>58</fpage>
            <page-range>58-61</page-range>
            <pub-id pub-id-type="pmid">28538745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schultheis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grabbe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Staubach</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hennig</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mauch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burckhardt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Heise</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zamsheva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schollenberger</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Strobel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Drivers of disease severity and burden of hidradenitis suppurativa: a cross-sectional analysis on 553 German patients.</article-title>
            <source>Int J Dermatol</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-195</page-range>
            <pub-id pub-id-type="pmid">37919257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolinska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Andrawis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beatty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Costa Blasco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mc Feely</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tobin</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Social Media Content on Hidradenitis Suppurativa: A Cross-Sectional Study.</article-title>
            <source>Dermatology</source>
            <year>2023</year>
            <volume>239</volume>
            <issue>5</issue>
            <fpage>840</fpage>
            <page-range>840-842</page-range>
            <pub-id pub-id-type="pmid">37231820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheinfeld</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.</article-title>
            <source>Dermatol Online J</source>
            <year>2013</year>
            <month>Nov</month>
            <day>15</day>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>20616</fpage>
            <pub-id pub-id-type="pmid">24314785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandez</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Borgstrom</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orenstein</surname>
                <given-names>LAV</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VY</given-names>
              </name>
            </person-group>
            <article-title>Pain management modalities for hidradenitis suppurativa: a patient survey.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2022</year>
            <month>May</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>1742</fpage>
            <page-range>1742-1745</page-range>
            <pub-id pub-id-type="pmid">32914659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richards</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Psychosocial effects of hidradenitis suppurativa in the literature: A systematic review.</article-title>
            <source>Int J Psychiatry Med</source>
            <year>2024</year>
            <month>Apr</month>
            <day>21</day>
            <fpage>912174241249215</fpage>
            <pub-id pub-id-type="pmid">38644350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuenca-Barrales</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Montero-Vilchez</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Krajewski</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Szepietowski</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Matusiak</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arias-Santiago</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molina-Leyva</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2022</year>
            <month>Dec</month>
            <day>26</day>
            <volume>20</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">36612709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matusiak</surname>
                <given-names>&#x00141;</given-names>
              </name>
            </person-group>
            <article-title>Profound consequences of hidradenitis suppurativa: a review.</article-title>
            <source>Br J Dermatol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>183</volume>
            <issue>6</issue>
            <fpage>e171</fpage>
            <page-range>e171-e177</page-range>
            <pub-id pub-id-type="pmid">29744872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pascual</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Quiles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Garc&#x000ed;a</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Viudez-Mart&#x000ed;nez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belinch&#x000f3;n Romero</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sivera Mascar&#x000f3;</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Topical and Intralesional Therapies for Hidradenitis Suppurativa: A Systematic Literature Review.</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2024</year>
            <month>May</month>
            <volume>115</volume>
            <issue>5</issue>
            <fpage>T433</fpage>
            <page-range>T433-T448</page-range>
            <pub-id pub-id-type="pmid">38423507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katoulis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Efthymiou</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Liakou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pappa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kanelleas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koumaki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bozi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sgouros</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Resorcinol 10% as a Promising Therapeutic Option for Mild Hidradenitis Suppurativa: A Prospective, Randomized, Open Study.</article-title>
            <source>Skin Appendage Disord</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>438</fpage>
            <page-range>438-443</page-range>
            <pub-id pub-id-type="pmid">38058541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Rehman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Daveluy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Punch debridement (mini-deroofing): An in-office surgical option for hidradenitis suppurativa.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2024</year>
            <month>Jan</month>
            <day>09</day>
            <pub-id pub-id-type="pmid">38211709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Advances in surgical treatment of hidradenitis suppurative.</article-title>
            <source>Zhejiang Da Xue Xue Bao Yi Xue Ban</source>
            <year>2023</year>
            <month>Nov</month>
            <day>02</day>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>795</fpage>
            <page-range>795-801</page-range>
            <pub-id pub-id-type="pmid">37986703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clemmensen</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <article-title>Topical treatment of hidradenitis suppurativa with clindamycin.</article-title>
            <source>Int J Dermatol</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>325</fpage>
            <page-range>325-8</page-range>
            <pub-id pub-id-type="pmid">6347922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2023</year>
            <month>Aug</month>
            <day>01</day>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>785</fpage>
            <page-range>785-794</page-range>
            <pub-id pub-id-type="pmid">37556513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baroudi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bashyam</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Pichardo</surname>
                <given-names>RO</given-names>
              </name>
            </person-group>
            <article-title>Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2023</year>
            <month>Nov</month>
            <day>01</day>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>e12</fpage>
            <page-range>e12-e16</page-range>
            <pub-id pub-id-type="pmid">37943259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ingram</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cannings-John</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Howells</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Howes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leighton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Thomas-Jones</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Hidradenitis Suppurativa Evaluation Study: the THESEUS prospective cohort study.</article-title>
            <source>Health Technol Assess</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>30</issue>
            <fpage>1</fpage>
            <page-range>1-107</page-range>
            <pub-id pub-id-type="pmid">38149635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malvaso</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chiricozzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fossati</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Peris</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of a combined pharmacological and surgical approach in patients affected by hidradenitis suppurativa: data from a retrospective real-world clinical study.</article-title>
            <source>Ital J Dermatol Venerol</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>159</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-195</page-range>
            <pub-id pub-id-type="pmid">38650499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stergianou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kanni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Damoulari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giamarellos-Bourboulis</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa.</article-title>
            <source>Expert Opin Biol Ther</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>225</fpage>
            <page-range>225-232</page-range>
            <pub-id pub-id-type="pmid">38602836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez-D&#x000ed;az</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az-Calvillo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Pozo</surname>
                <given-names>J&#x000c1;</given-names>
              </name>
              <name>
                <surname>Arias-Santiago</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molina-Leyva</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness and Safety of Acitretin for the Treatment of Hidradenitis Suppurativa, Predictors of Clinical Response: A Cohort Study.</article-title>
            <source>Dermatology</source>
            <year>2023</year>
            <volume>239</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-59</page-range>
            <pub-id pub-id-type="pmid">35998603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ring</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Thorsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ingram</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rosen&#x000f8;</surname>
                <given-names>NAL</given-names>
              </name>
              <name>
                <surname>Holgersen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Thein Aagaard</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Maul</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Thyssen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Egeberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.</article-title>
            <source>Br J Dermatol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>17</day>
            <volume>190</volume>
            <issue>5</issue>
            <fpage>769</fpage>
            <page-range>769-771</page-range>
            <pub-id pub-id-type="pmid">38305415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husein-ElAhmed</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Husein-ElAhmed</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparative efficacy and therapeutic positioning of biologics in hidradenitis suppurativa: A systematic review with network meta-analysis of randomised trials.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2024</year>
            <month>Feb</month>
            <day>28</day>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">38595016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tchernev</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.</article-title>
            <source>Georgian Med News</source>
            <year>2023</year>
            <season>Jul-Aug</season>
            <issue>340-341</issue>
            <fpage>297</fpage>
            <page-range>297-300</page-range>
            <pub-id pub-id-type="pmid">37805915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bevilacqua</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manzo Margiotta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Michelucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Granieri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fidanzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Romanelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mazzatenta</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.</article-title>
            <source>Australas J Dermatol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">38597123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gulliver</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Prens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Tzellos</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.</article-title>
            <source>Rev Endocr Metab Disord</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-351</page-range>
            <pub-id pub-id-type="pmid">26831295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hazen</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hazen</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization.</article-title>
            <source>Dermatol Surg</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>208</fpage>
            <page-range>208-13</page-range>
            <pub-id pub-id-type="pmid">20039918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tricarico</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Zupin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ottaviani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rupel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Celsi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Genovese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boniotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crovella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marzano</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Photobiomodulation as potential novel third line tool for non-invasive treatment of hidradenitis suppurativa.</article-title>
            <source>G Ital Dermatol Venereol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>155</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-98</page-range>
            <pub-id pub-id-type="pmid">31042851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hamaguchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kimball</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Orgill</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Plastic Surgical Management of Hidradenitis Suppurativa.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2021</year>
            <month>Mar</month>
            <day>01</day>
            <volume>147</volume>
            <issue>3</issue>
            <fpage>479</fpage>
            <page-range>479-491</page-range>
            <pub-id pub-id-type="pmid">33620946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Soti</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of Surgical Deroofing and Carbon Dioxide Laser in Moderate-to-Severe Hidradenitis Suppurativa Patients.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>e56959</fpage>
            <pub-id pub-id-type="pmid">38545424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>La Padula</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pensato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pizza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D'Andrea</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Roccaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Meningaud</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hersant</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The Thoracodorsal Artery Perforator Flap for the Treatment of Hidradenitis Suppurativa of the Axilla: A Prospective Comparative Study.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2023</year>
            <month>Nov</month>
            <day>01</day>
            <volume>152</volume>
            <issue>5</issue>
            <fpage>1105</fpage>
            <page-range>1105-1116</page-range>
            <pub-id pub-id-type="pmid">36946904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinnicombe</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Spiers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pouncey</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>McEvoy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lancaster</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Negative Pressure Wound Therapy with or without a Split-Thickness Skin Graft in the Surgical Management of Axillary Hidradenitis Suppurativa: A Retrospective Cohort Study.</article-title>
            <source>Plast Surg (Oakv)</source>
            <year>2024</year>
            <month>May</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>314</fpage>
            <page-range>314-320</page-range>
            <pub-id pub-id-type="pmid">38681254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasslitter</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>H&#x000e4;fner</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kofler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kofler</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Postoperative wound care with custom-made wound dressings for hidradenitis suppurativa : Wound care after radical excision with secondary wound closure].</article-title>
            <source>Dermatologie (Heidelb)</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>12</issue>
            <fpage>994</fpage>
            <page-range>994-996</page-range>
            <pub-id pub-id-type="pmid">37910227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKenzie</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Jun</month>
            <day>22</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>e4970</fpage>
            <pub-id pub-id-type="pmid">31453042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Yazdanyar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ernst Jemec</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Saunte</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Concomitant Hidradenitis Suppurativa and Eruptive Xanthomas Presenting with Phimosis - The Importance of Timely Diagnosis.</article-title>
            <source>Acta Dermatovenerol Croat</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>154</fpage>
            <page-range>154-156</page-range>
            <pub-id pub-id-type="pmid">33422169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shamim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Riemer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Weenig</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sokumbi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sciallis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McEvoy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mischke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Comfere</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Acneiform Presentations of Folliculotropic Mycosis Fungoides.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2021</year>
            <month>Feb</month>
            <day>01</day>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-92</page-range>
            <pub-id pub-id-type="pmid">33492839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyakhovitsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Galili</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Tzanani</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scope</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>12</issue>
            <fpage>1469</fpage>
            <page-range>1469-1477</page-range>
            <pub-id pub-id-type="pmid">37875786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kromann</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Deckers</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Esmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prens</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Jemec</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study.</article-title>
            <source>Br J Dermatol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>171</volume>
            <issue>4</issue>
            <fpage>819</fpage>
            <page-range>819-24</page-range>
            <pub-id pub-id-type="pmid">24804604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuan</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Complications of hidradenitis suppurativa.</article-title>
            <source>Semin Cutan Med Surg</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">28538749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yaman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>E&#x0015f;me</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>&#x000c7;al&#x00131;&#x0015f;kan</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Complex decongestive therapy in hidradenitis suppurativa-related genital lymphoedema: a case report.</article-title>
            <source>J Wound Care</source>
            <year>2024</year>
            <month>Feb</month>
            <day>01</day>
            <volume>33</volume>
            <issue>Sup2a</issue>
            <fpage>xxviii</fpage>
            <page-range>xxviii-xxxi</page-range>
            <pub-id pub-id-type="pmid">38324423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mac Mahon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McCartney</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tobin</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Molloy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Systemic AA amyloidosis in hidradenitis suppurativa: Should we be screening?</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2023</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>e600</fpage>
            <page-range>e600-e601</page-range>
            <pub-id pub-id-type="pmid">36463423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuraitis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Murina</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Squamous Cell Carcinoma Arising in Chronic Inflammatory Dermatoses.</article-title>
            <source>Cutis</source>
            <year>2024</year>
            <month>Jan</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">38478947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sidur</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cuff</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kaymakcalan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ruzek</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa.</article-title>
            <source>Br J Dermatol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>185</volume>
            <issue>4</issue>
            <fpage>804</fpage>
            <page-range>804-814</page-range>
            <pub-id pub-id-type="pmid">33811319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22863.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimball</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Sundaram</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gauthier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gu&#x000e9;rin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pivneva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ganguli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.</article-title>
            <source>Dermatol Ther (Heidelb)</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-569</page-range>
            <pub-id pub-id-type="pmid">30306395</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
